A detailed history of Journey Advisory Group, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Journey Advisory Group, LLC holds 5,040 shares of EW stock, worth $341,510. This represents 0.04% of its overall portfolio holdings.

Number of Shares
5,040
Previous 5,040 -0.0%
Holding current value
$341,510
Previous $465,000 28.6%
% of portfolio
0.04%
Previous 0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$84.3 - $94.31 $320,255 - $358,283
-3,799 Reduced 42.98%
5,040 $465,000
Q1 2024

May 09, 2024

SELL
$72.54 - $95.56 $250,625 - $330,159
-3,455 Reduced 28.1%
8,839 $844,000
Q4 2023

Feb 12, 2024

SELL
$61.71 - $77.76 $46,282 - $58,320
-750 Reduced 5.75%
12,294 $937,000
Q3 2023

Nov 15, 2023

SELL
$69.28 - $93.38 $105,652 - $142,404
-1,525 Reduced 10.47%
13,044 $903,000
Q2 2023

Aug 09, 2023

SELL
$81.41 - $94.33 $228,762 - $265,067
-2,810 Reduced 16.17%
14,569 $1.37 Million
Q1 2023

May 04, 2023

SELL
$74.26 - $84.51 $431,450 - $491,003
-5,810 Reduced 25.05%
17,379 $1.44 Million
Q4 2022

Feb 07, 2023

SELL
$68.3 - $87.44 $192,947 - $247,018
-2,825 Reduced 10.86%
23,189 $1.73 Million
Q3 2022

Nov 09, 2022

BUY
$82.37 - $107.29 $24,711 - $32,187
300 Added 1.17%
26,014 $2.15 Million
Q2 2022

Aug 02, 2022

SELL
$86.5 - $128.27 $179,055 - $265,518
-2,070 Reduced 7.45%
25,714 $2.56 Million
Q3 2021

Nov 12, 2021

SELL
$102.91 - $122.75 $150,763 - $179,828
-1,465 Reduced 5.01%
27,784 $3.15 Million
Q2 2021

Aug 13, 2021

SELL
$83.84 - $104.76 $7,545 - $9,428
-90 Reduced 0.31%
29,249 $3.03 Million
Q1 2021

May 11, 2021

SELL
$78.68 - $90.67 $14,949 - $17,227
-190 Reduced 0.64%
29,339 $2.45 Million
Q4 2020

Jan 19, 2021

BUY
$71.69 - $91.23 $2.12 Million - $2.69 Million
29,529 New
29,529 $2.69 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Journey Advisory Group, LLC Portfolio

Follow Journey Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Journey Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Journey Advisory Group, LLC with notifications on news.